Hemispherx Biopharma, Inc.

Company Listings from SPi: Hemispherx Biopharma, Inc.

You are here: Home >> SPi Company Listings >> Hemispherx Biopharma, Inc.

 

Hemispherx Biopharma, Inc.

Website:
http://

Search for other references to "hemispherx" on SPi News

Latest Hemispherx Biopharma, Inc. News

Hemispherx Reports Six Months Ended June 30, 2018 Financial Results and Provides Business Update OCALA, Fla., Aug. 15, 2018 (GLOBE NEWSWIRE) -- (NYSE American:HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, has...... 13:38 GMT Wednesday 15th August 2018

Hemispherx Updates Stockholders, Highlighting Ampligen’s Role in Enhancing Immunotherapeutic Therapies OCALA, Fla., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medic...... 13:30 GMT Monday 13th August 2018

Hemispherx Files Positive Safety Report on Intranasal Use of Ampligen in Combination with FluMist Influenza Vaccine ORLANDO, Fla., July 09, 2018 (GLOBE NEWSWIRE) -- (NYSE American:HEB) announced the filing of a clinical study report on AMP-600, a Phase I/II trial of intranasal Ampligen® in...... 13:30 GMT Monday 9th July 2018

Hemispherx Notes the Importance of Immunizations During Upcoming National Immunization Awareness Month and Potential of Ampligen in Influenza Vaccine Strategies ORLANDO, Fla., July 03, 2018 (GLOBE NEWSWIRE) -- (NYSE American:HEB), an immuno-pharma R&D company focused on unmet medical needs in immunology, is pleased to enthusiastically su...... 13:30 GMT Tuesday 3rd July 2018

Hemispherx Opens FDA-Approved Reimbursement Based Expanded Access Treatment Program for ME/CFS to New Enrollees at Approved Clinical Sites in Nevada and North Carolina ORLANDO, Fla., June 27, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) has announced the immediate expansion of its Treatment Protocol/Expanded Access Pr...... 13:30 GMT Wednesday 27th June 2018

Hemispherx Releases First 8,500 Vial Lot of Ampligen to Supply Expanded Access Programs in the United States, Europe and Canada for ME/CFS and Pancreatic Cancer and Announces Successful Finish of Second Commercial Size Lot ORLANDO, Fla., June 15, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) has announced the successful completion of the first phase of its Ampligen product...... 15:19 GMT Friday 15th June 2018

Hemispherx Announces New Data Showing Ampligen’s Positive Role in Reprograming Tumor Microenvironment ORLANDO, Fla., June 05, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) announced today that its TLR3 agonist Ampligen outperformed two other TLR3 agonist...... 16:21 GMT Tuesday 5th June 2018

Hemispherx Biopharma and Roswell Park Plan Phase I/II Study of Ampligen Plus Checkpoint Inhibitors ORLANDO, Fla., May 31, 2018 (GLOBE NEWSWIRE) -- Roswell Park Comprehensive Cancer Center (Roswell Park) and Hemispherx Biopharma, Inc. (NYSE American:HEB) plan to expand their ex...... 13:30 GMT Thursday 31st May 2018

CORRECTING AND REPLACING: Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update ORLANDO, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today by Hemispherx Biopharma, Inc. (NYSE American:HEB) with the same headline, the net loss from ope...... 19:19 GMT Wednesday 16th May 2018

Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update ORLANDO, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- (NYSE American:HEB), an advanced specialty pharmaceutical company engaged in the treatment of serious and debilitating disorders t...... 13:30 GMT Wednesday 16th May 2018

Buy Hemispherx Biopharma, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers